Drug firm Granules India today reported a 5.54 per cent decline in its consolidated net profit at Rs 36.80 crore for the quarter to June.
The company had posted net profit of Rs 38.96 crore in the year-ago quarter, Granules India said in a filing to the BSE.
Consolidated total income, however, rose to Rs 386.33 crore in April-June, from Rs 352.83 crore in the same period a year ago, it added.
The board has approved interim dividend of 25 paise per share with face value of Re 1 each, Granules India said.
The stock today closed at Rs 116.45 on the BSE, up 6.49 per cent from its previous close.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)